Jian-Ying Zhang - Publications

Affiliations: 
Biological Sciences University of Texas at El Paso, El Paso, TX, United States 
Area:
Molecular Biology

28 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Koziol JA, Imai H, Dai L, Zhang JY, Tan EM. Early detection of hepatocellular carcinoma using autoantibody profiles from a panel of tumor-associated antigens. Cancer Immunology, Immunotherapy : Cii. PMID 29497780 DOI: 10.1007/s00262-018-2135-y  0.56
2017 Dai L, Li J, Tsay JJ, Yie TA, Munger JS, Pass H, Rom WN, Tan EM, Zhang JY. Identification of autoantibodies to ECH1 and HNRNPA2B1 as potential biomarkers in the early detection of lung cancer. Oncoimmunology. 6: e1310359. PMID 28638733 DOI: 10.1080/2162402X.2017.1310359  0.56
2016 Dai L, Tsay JC, Li J, Yie TA, Munger JS, Pass H, Rom WN, Zhang Y, Tan EM, Zhang JY. Autoantibodies against tumor-associated antigens in the early detection of lung cancer. Lung Cancer (Amsterdam, Netherlands). 99: 172-9. PMID 27565936 DOI: 10.1016/j.lungcan.2016.07.018  0.56
2016 Zhang HF, Qin JJ, Ren PF, Shi JX, Xia JF, Ye H, Wang P, Song CH, Wang KJ, Zhang JY. A panel of autoantibodies against multiple tumor-associated antigens in the immunodiagnosis of esophageal squamous cell cancer. Cancer Immunology, Immunotherapy : Cii. PMID 27553002 DOI: 10.1007/s00262-016-1886-6  0.56
2016 Luo CL, Liu YQ, Wang P, Song CH, Wang KJ, Dai LP, Zhang JY, Ye H. The effect of quercetin nanoparticle on cervical cancer progression by inducing apoptosis, autophagy and anti-proliferation via JAK2 suppression. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 82: 595-605. PMID 27470402 DOI: 10.1016/j.biopha.2016.05.029  0.56
2016 Dai L, Li J, Xing M, Sanchez TW, Casiano CA, Zhang JY. Using serological proteome analysis to identify serum anti-nucleophosmin 1 autoantibody as a potential biomarker in European-American and African-American patients with prostate cancer. The Prostate. PMID 27418398 DOI: 10.1002/pros.23217  0.56
2016 Dai L, Peng XX, Tan EM, Zhang JY. Tumor-associated antigen CAPERα and microvessel density in hepatocellular carcinoma. Oncotarget. PMID 26934653 DOI: 10.18632/oncotarget.7707  0.56
2015 Guo C, Peng B, Song M, Wu CW, Yang MJ, Zhang JY, Li H. Live Edwardsiella tarda Vaccine Enhances Innate Immunity by Metabolic Modulation in Zebrafish. Fish & Shellfish Immunology. PMID 26394266 DOI: 10.1016/j.fsi.2015.09.034  0.56
2015 Zhou JW, Li Y, Yue LX, Luo CL, Chen Y, Zhang JY. Autoantibody response to Sui1 and its tissue-specific expression in hepatocellular carcinoma. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 26386724 DOI: 10.1007/s13277-015-4074-y  0.56
2015 Peng B, Ma YM, Zhang JY, Li H. Metabolome strategy against Edwardsiella tarda infection through glucose-enhanced metabolic modulation in tilapias. Fish & Shellfish Immunology. 45: 869-76. PMID 26057462 DOI: 10.1016/j.fsi.2015.06.004  0.56
2015 Zhu Q, Han SX, Zhou CY, Cai MJ, Dai LP, Zhang JY. Autoimmune response to PARP and BRCA1/BRCA2 in cancer. Oncotarget. 6: 11575-84. PMID 25865228  0.56
2015 Peng B, Lei N, Chai Y, Chan EK, Zhang JY. CIP2A regulates cancer metabolism and CREB phosphorylation in non-small cell lung cancer. Molecular Biosystems. 11: 105-14. PMID 25325377 DOI: 10.1039/c4mb00513a  0.56
2014 Lei N, Peng B, Zhang JY. CIP2A regulates cell proliferation via the AKT signaling pathway in human lung cancer. Oncology Reports. 32: 1689-94. PMID 25109354 DOI: 10.3892/or.2014.3375  0.56
2014 Liu X, Peng B, Li Y, Lei N, Li W, Zhang JY. p90/CIP2A mediates breast cancer cell proliferation and apoptosis. Molecular Biology Reports. 41: 7471-8. PMID 25086622 DOI: 10.1007/s11033-014-3635-2  0.56
2014 Dai L, Ren P, Liu M, Imai H, Tan EM, Zhang JY. Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma. Clinical Immunology (Orlando, Fla.). 152: 127-39. PMID 24667685 DOI: 10.1016/j.clim.2014.03.007  0.56
2013 Rico CM, Hong J, Morales MI, Zhao L, Barrios AC, Zhang JY, Peralta-Videa JR, Gardea-Torresdey JL. Effect of cerium oxide nanoparticles on rice: a study involving the antioxidant defense system and in vivo fluorescence imaging. Environmental Science & Technology. 47: 5635-42. PMID 23662857 DOI: 10.1021/es401032m  0.56
2013 Peng B, Huang X, Nakayasu ES, Petersen JR, Qiu S, Almeida IC, Zhang JY. Using immunoproteomics to identify alpha-enolase as an autoantigen in liver fibrosis. Journal of Proteome Research. 12: 1789-96. PMID 23458688 DOI: 10.1021/pr3011342  0.56
2012 Zhao L, Peng B, Hernandez-Viezcas JA, Rico C, Sun Y, Peralta-Videa JR, Tang X, Niu G, Jin L, Varela-Ramirez A, Zhang JY, Gardea-Torresdey JL. Stress response and tolerance of Zea mays to CeO2 nanoparticles: cross talk among H2O2, heat shock protein, and lipid peroxidation. Acs Nano. 6: 9615-22. PMID 23050848 DOI: 10.1021/nn302975u  0.56
2010 Zhang JY, Tan EM. Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors. Expert Review of Molecular Diagnostics. 10: 321-8. PMID 20370589 DOI: 10.1586/erm.10.12  0.56
2010 Chen Y, Zhou Y, Qiu S, Wang K, Liu S, Peng XX, Li J, Tan EM, Zhang JY. Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma. Cancer Letters. 289: 32-9. PMID 19683863 DOI: 10.1016/j.canlet.2009.07.016  0.56
2009 Zhang JY, Looi KS, Tan EM. Identification of tumor-associated antigens as diagnostic and predictive biomarkers in cancer. Methods in Molecular Biology (Clifton, N.J.). 520: 1-10. PMID 19381943 DOI: 10.1007/978-1-60327-811-9_1  0.56
2008 Looi KS, Nakayasu ES, Diaz RA, Tan EM, Almeida IC, Zhang JY. Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma. Journal of Proteome Research. 7: 4004-12. PMID 18672925 DOI: 10.1021/pr800273h  0.56
2007 Ersvaer E, Zhang JY, McCormack E, Olsnes A, Anensen N, Tan EM, Gjertsen BT, Bruserud O. Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia-associated antigen associated with autoantibody response in a subset of patients. European Journal of Haematology. 79: 210-25. PMID 17655707 DOI: 10.1111/j.1600-0609.2007.00899.x  0.56
2007 Zhang JY, Megliorino R, Peng XX, Tan EM, Chen Y, Chan EK. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma. Journal of Hepatology. 46: 107-14. PMID 17067715 DOI: 10.1016/j.jhep.2006.08.010  0.56
2005 Himoto T, Kuriyama S, Zhang JY, Chan EK, Kimura Y, Masaki T, Uchida N, Nishioka M, Tan EM. Analyses of autoantibodies against tumor-associated antigens in patients with hepatocellular carcinoma. International Journal of Oncology. 27: 1079-85. PMID 16142326  0.56
2005 Megliorino R, Shi FD, Peng XX, Wang X, Chan EK, Tan EM, Zhang JY. Autoimmune response to anti-apoptotic protein survivin and its association with antibodies to p53 and c-myc in cancer detection. Cancer Detection and Prevention. 29: 241-8. PMID 15896923 DOI: 10.1016/j.cdp.2005.03.002  0.56
2005 Himoto T, Kuriyama S, Zhang JY, Chan EK, Nishioka M, Tan EM. Significance of autoantibodies against insulin-like growth factor II mRNA-binding proteins in patients with hepatocellular carcinoma. International Journal of Oncology. 26: 311-7. PMID 15645114  0.56
2005 Shi FD, Zhang JY, Liu D, Rearden A, Elliot M, Nachtsheim D, Daniels T, Casiano CA, Heeb MJ, Chan EK, Tan EM. Preferential humoral immune response in prostate cancer to cellular proteins p90 and p62 in a panel of tumor-associated antigens. The Prostate. 63: 252-8. PMID 15538718 DOI: 10.1002/pros.20181  0.56
Show low-probability matches.